Basic and Clinical Research Progress of Immunotherapy for Hepatocellular Carcinoma

Primary liver cancer, especially hepatocellular carcinoma, poses a serious threat to the life and health of the Chinese people. Given the insidious onset of liver cancer, less than 30% of hepatocellular carcinoma patients are considered for radical treatment at the initial diagnosis. Systemic anti-t...

Full description

Bibliographic Details
Main Authors: ZHANG Zechuan, SUN Beicheng
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2023-04-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1202
_version_ 1797830035608961024
author ZHANG Zechuan
SUN Beicheng
author_facet ZHANG Zechuan
SUN Beicheng
author_sort ZHANG Zechuan
collection DOAJ
description Primary liver cancer, especially hepatocellular carcinoma, poses a serious threat to the life and health of the Chinese people. Given the insidious onset of liver cancer, less than 30% of hepatocellular carcinoma patients are considered for radical treatment at the initial diagnosis. Systemic anti-tumor therapy plays an important role in the treatment of advanced hepatocellular carcinoma. Immunotherapy of hepatocellular carcinoma has developed rapidly, and an increasing number of immunotherapy drugs, which can better control the progress of hepatocellular carcinoma and prolong the survival of patients, have become first- and second-line treatment options. This article reviews briefly the progress of immunotherapy for hepatocellular carcinoma in recent years.
first_indexed 2024-04-09T13:29:39Z
format Article
id doaj.art-6e307857d91440b9ba1eb1f2d5ee8980
institution Directory Open Access Journal
issn 1000-8578
language zho
last_indexed 2024-04-09T13:29:39Z
publishDate 2023-04-01
publisher Magazine House of Cancer Research on Prevention and Treatment
record_format Article
series Zhongliu Fangzhi Yanjiu
spelling doaj.art-6e307857d91440b9ba1eb1f2d5ee89802023-05-10T04:57:52ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85782023-04-0150434540010.3971/j.issn.1000-8578.2023.22.12028578.2023.22.1202Basic and Clinical Research Progress of Immunotherapy for Hepatocellular CarcinomaZHANG Zechuan0SUN Beicheng1Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, ChinaDepartment of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, ChinaPrimary liver cancer, especially hepatocellular carcinoma, poses a serious threat to the life and health of the Chinese people. Given the insidious onset of liver cancer, less than 30% of hepatocellular carcinoma patients are considered for radical treatment at the initial diagnosis. Systemic anti-tumor therapy plays an important role in the treatment of advanced hepatocellular carcinoma. Immunotherapy of hepatocellular carcinoma has developed rapidly, and an increasing number of immunotherapy drugs, which can better control the progress of hepatocellular carcinoma and prolong the survival of patients, have become first- and second-line treatment options. This article reviews briefly the progress of immunotherapy for hepatocellular carcinoma in recent years.http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1202primary liver cancerhepatocellular carcinomaimmunotherapysystemic therapy
spellingShingle ZHANG Zechuan
SUN Beicheng
Basic and Clinical Research Progress of Immunotherapy for Hepatocellular Carcinoma
Zhongliu Fangzhi Yanjiu
primary liver cancer
hepatocellular carcinoma
immunotherapy
systemic therapy
title Basic and Clinical Research Progress of Immunotherapy for Hepatocellular Carcinoma
title_full Basic and Clinical Research Progress of Immunotherapy for Hepatocellular Carcinoma
title_fullStr Basic and Clinical Research Progress of Immunotherapy for Hepatocellular Carcinoma
title_full_unstemmed Basic and Clinical Research Progress of Immunotherapy for Hepatocellular Carcinoma
title_short Basic and Clinical Research Progress of Immunotherapy for Hepatocellular Carcinoma
title_sort basic and clinical research progress of immunotherapy for hepatocellular carcinoma
topic primary liver cancer
hepatocellular carcinoma
immunotherapy
systemic therapy
url http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1202
work_keys_str_mv AT zhangzechuan basicandclinicalresearchprogressofimmunotherapyforhepatocellularcarcinoma
AT sunbeicheng basicandclinicalresearchprogressofimmunotherapyforhepatocellularcarcinoma